Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regeneration Technologies, Inc.

This article was originally published in The Gray Sheet

Executive Summary

Alachua, Fla. firm plans to conduct clinical trials to extend use of its BioCleanse sterilization process to RTI heart valves and osteochondral grafts. Available since March 2000, the process currently is used to sterilize the company's bone tissue products. Beginning March 1, the latter RTI products will be labeled "sterile" for the first time based on ISO and AAMI standards. RTI announced the "official" launch of the BioCleanse system encompassing product and package sterilization processes Feb. 5...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT017916

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel